CanFite BioPharma Public
CanFite BioPharma is a bio-pharmaceutical company based in Israel. They have a strong focus on pharmaceutical discovery and clinical development. With a pipeline of proprietary compounds in phase 2 and 3 clinical development, their main goal is to address autoimmune-inflammatory and cancer diseases. CanFite BioPharma has achieved significant advancements in their research and development, positioning themselves as a leading player in the biopharmaceutical industry.
%20.jpg)
Funding Status:
IPO
Investors Number:
4
Estimated Revenue:
$1M to $10M
Total Funding:
$51.4M
Industry:
PharmTech
Employee Number:
1-10
Investment Stage:
N/A
Headquarters:
Petah Tiqva, HaMerkaz, Israel
Founded Date:
1994-01-01
Last Funding Type:
Post-IPO Equity
Technology:
Drug development
Number Of Exists:
Post-IPO Equity
Investor Type:
Company